Long-term efficacy and safety of atypical and conventional antipsychotic drugs in first episode schizophrenia

被引：1
|
作者：
Sharma, T
Lieberman, JA
McEvoy, JP
Perkins, DO
Hamer, RM
Zipursky, RB
Kahn, RS
Gur, RE
Centorrino, F
Glick, I
Green, AI
Nemeroff, CB
Rothschild, AJ
Strakowski, SM
Tohen, M
Tollefson, GD
机构：
[1] Clin Neurosci Res Ctr, Res, Dartford, England
[2] Univ N Carolina, Sch Med, Mental Hlth & Neurosci Clin Res C, Chapel Hill, NC USA
[3] John Umstead Hosp, Butner, NC USA
[4] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA
[5] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[6] Univ Med Ctr, Dept Psychiat, Utrecht, Netherlands
[7] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA
[8] Harvard Univ, Sch Med, Bipolar & Psychot Disorders Clin, Belmont, MA 02178 USA
[9] Stanford Univ, Sci Stanford Univ Med Ctr, Stanford, CA 94305 USA
[10] Univ Hartford, Sch Med, Massachusetts Mental Hlth Ctr, Boston, MA USA
[11] Emory Univ, Sch Med, Atlanta, GA 30322 USA
[12] Univ Massachusetts, Sch Med, Clin Res, Boston, MA 02125 USA
[13] Univ Cincinnati, Cincinnati, OH 45221 USA
[14] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2003年 / 13卷
关键词：
D O I：
10.1016/S0924-977X(03)91655-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S134 / S135
页数：2
相关论文
共 50 条
  • [11] Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: A randomized, double-blind trial of olanzapine versus haloperidol
    Lieberman, JA
    Tollefson, G
    Tohen, M
    Green, AI
    Gur, RE
    Kahn, R
    McEvoy, J
    Perkins, D
    Sharma, T
    Zipursky, R
    Wei, H
    Hamer, RM
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (08): : 1396 - 1404
  • [12] Pilot study of atypical antipsychotic agents in first episode schizophrenia
    Robinson, DG
    Lieberman, JA
    Sheitman, B
    Alvir, JMJ
    Kane, JM
    [J]. SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 196 - 196
  • [13] A review, of atypical antipsychotic drugs versus conventional medication in schizophrenia
    Luft, Barrat
    Taylor, David
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (13) : 1739 - 1748
  • [14] A comparison of long-term outcome in first-episode schizophrenia following treatment with risperidone or a typical antipsychotic
    Malla, AK
    Norman, RMG
    Scholten, DJ
    Zirul, S
    Kotteda, V
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (03) : 179 - 184
  • [15] Safety and related factors of treatment with long-term atypical antipsychotic in Chinese patients with schizophrenia: observational study
    Yu, Wenjuan
    Huang, Jingjing
    He, Sidi
    Zhang, Lei
    Shen, Yifeng
    Li, Huafang
    [J]. GENERAL PSYCHIATRY, 2021, 34 (01)
  • [16] Safety and related factors of treatment with long-term atypical antipsychotic in Chinese patients with schizophrenia:observational study
    Wenjuan Yu
    Jingjing Huang
    Sidi He
    Lei Zhang
    Yifeng Shen
    Huafang Li
    [J]. 上海精神医学, 2021, (01) : 37 - 43
  • [17] Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses
    Stewart, D. W.
    Turner, M. S.
    [J]. EUROPEAN PSYCHIATRY, 2007, 22 : S168 - S168
  • [18] Antipsychotic Drugs for First-Episode Schizophrenia A Comparative Review
    Salimi, Kayvon
    Jarskog, L. Fredrik
    Lieberman, Jeffrey A.
    [J]. CNS DRUGS, 2009, 23 (10) : 837 - 855
  • [19] Atypical antipsychotic drugs for schizophrenia
    Luh, JY
    [J]. MAYO CLINIC PROCEEDINGS, 2003, 78 (03) : 381 - 382
  • [20] Efficacy of Antipsychotic Drugs Against Hostility in the European First-Episode Schizophrenia Trial (EUFEST)
    Volavka, Jan
    Czobor, Pal
    Derks, Eske M.
    Bitter, Istvan
    Libiger, Jan
    Kahn, Rene S.
    Fleischhacker, W. Wolfgang
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (07) : 955 - 961
12345